Skip to main content
. 2023 Mar 27;2023(3):CD009885. doi: 10.1002/14651858.CD009885.pub3

12.2. Analysis.

12.2

Comparison 12: Additional subgroup analyses of general behaviour, Outcome 2: Parallel‐group trials and first‐period cross‐over trials: comorbidity versus no comorbidity